Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Duquesne University
Age
Any age
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
postmenopausal
must be osteopenic (T-score between -2.5 and -1)
willingness to participate in the 12-month study
willingness to undergo testing of bone turnover markers before and after the drug therapies
willingness to provide a self-assessment on quality of life throughout the program
willingness to take their treatments right before bed
willingness to not to consume alcohol with this medication
You may not be if
women in whom osteopenia is a result of some other known process (e.g. hyperparathyroidism, metastatic bone disease, multiple myeloma or chronic steroid use).
women on osteoporotic drugs, hypnotics, CYP1A2 inhibiting drugs, fluvoxamine
women with severe sleep apnea, severe COPD and those with moderate or severe hepatic or renal impairment.
